Hill-Rom (HRC) Releases Q1 Earnings Guidance

Hill-Rom (NYSE:HRC) updated its first quarter earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.77-0.79 for the period, compared to the Thomson Reuters consensus estimate of $0.79. The company issued revenue guidance of $670 million, compared to the consensus revenue estimate of $656.42 million.

Several analysts have commented on the stock. Zacks Investment Research cut shares of Hill-Rom from a buy rating to a hold rating in a research note on Tuesday. Barclays reaffirmed a buy rating and issued a $100.00 target price on shares of Hill-Rom in a research note on Wednesday. ValuEngine cut shares of Hill-Rom from a buy rating to a hold rating in a research note on Saturday, November 4th. Stifel Nicolaus lifted their target price on shares of Hill-Rom from $84.00 to $85.00 and gave the stock a buy rating in a research note on Monday, November 6th. Finally, KeyCorp reaffirmed a buy rating and issued a $94.00 target price on shares of Hill-Rom in a research note on Thursday, December 21st. Six investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus price target of $93.00.

Shares of Hill-Rom (HRC) opened at $87.77 on Thursday. Hill-Rom has a 12 month low of $57.18 and a 12 month high of $88.91. The stock has a market cap of $5,780.00, a price-to-earnings ratio of 44.11, a PEG ratio of 1.65 and a beta of 1.19. The company has a current ratio of 1.77, a quick ratio of 1.34 and a debt-to-equity ratio of 1.55.

Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, November 3rd. The medical technology company reported $1.32 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.05. Hill-Rom had a net margin of 9.36% and a return on equity of 21.07%. The company had revenue of $738.30 million during the quarter, compared to analysts’ expectations of $731.10 million. During the same period in the previous year, the company earned $1.18 EPS. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. sell-side analysts predict that Hill-Rom will post 4.32 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Stockholders of record on Friday, December 15th were paid a dividend of $0.18 per share. The ex-dividend date of this dividend was Thursday, December 14th. This represents a $0.72 annualized dividend and a dividend yield of 0.82%. Hill-Rom’s dividend payout ratio is presently 36.18%.

In related news, CEO John J. Greisch sold 125,241 shares of Hill-Rom stock in a transaction on Friday, December 15th. The shares were sold at an average price of $82.59, for a total transaction of $10,343,654.19. Following the transaction, the chief executive officer now owns 280,851 shares in the company, valued at approximately $23,195,484.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Paul Sherwood Johnson sold 1,000 shares of Hill-Rom stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $82.99, for a total transaction of $82,990.00. Following the transaction, the senior vice president now owns 1,066 shares in the company, valued at approximately $88,467.34. The disclosure for this sale can be found here. Insiders have sold a total of 226,241 shares of company stock valued at $18,708,644 over the last three months. Corporate insiders own 2.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.com-unik.info/2018/01/11/hill-rom-hrc-releases-q1-earnings-guidance.html.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Earnings History and Estimates for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit